NRBF2 is involved in the autophagic degradation process of APP-CTFs in Alzheimer disease models

Autophagy

Volumn 13, Issue 12, 2017, Pages 2028-2040

  Yang, Chuanbin ^a   Cai, Cui Zan ^b   Song, Ju Xian ^a   Tan, Jie Qiong ^c   Durairajan, Siva Sundara Kumar ^a   Iyaswamy, Ashok ^a   Wu, Ming Yue ^b   Chen, Lei Lei ^a   Yue, Zhenyu ^d   Li, Min ^a   Lu, Jia Hong ^b  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b UNIVERSITY OF MACAU   (Macao)

^c Central South University   (China)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; APP; autophagy; A ; class III phosphatidylinositol 3 kinase (PtdIns3K); NRBF2

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; MEMBRANE PROTEIN; NUCLEAR RECEPTOR BINDING FACTOR 2; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSMEMBRANE PROTEIN APP; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; NRBF2 PROTEIN, MOUSE; PEPTIDE FRAGMENT; PROTEIN BINDING; TRANSCRIPTION FACTOR;

5XFAD MOUSE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CONTROLLED STUDY; ENDOSOME; HIPPOCAMPUS; HOMEOSTASIS; MOUSE; NERVE CELL; NONHUMAN; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; DISEASE MODEL; HUMAN; METABOLISM; PATHOLOGY; PROTEIN DEGRADATION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AUTOPHAGY; DISEASE MODELS, ANIMAL; ENDOSOMES; HIPPOCAMPUS; HUMANS; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEURONS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEOLYSIS; TRANSCRIPTION FACTORS;

EID: 85041203283     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.1080/15548627.2017.1379633     Document Type: Article

References (57)

1. O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Ann Rev Neurosci. 2011;34:185. doi:10.1146/annurev-neuro-061010-113613.
2. Krstic D, Knuesel I. Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2013;9:25–34. doi:10.1038/nrneurol.2012.236.
3. LaFerla FM, Green KN, Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nat Rev Neurosci. 2007;8:499–509. doi:10.1038/nrn2168.
4. Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harbor Perspect Med. 2012;2:a006270. doi:10.1101/cshperspect.a006270.
5. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R. APP processing and synaptic function. Neuron. 2003;37:925–37. doi:10.1016/S0896-6273(03)00124-7.
6. Hardy J, DJ S. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science. 2002;297:353–6. doi:10.1126/science.1072994.
7. van der Kant R, Goldstein LS. Cellular functions of the amyloid precursor protein from development to dementia. Dev Cell. 2015;32:502–15. doi:10.1016/j.devcel.2015.01.022.
8. Ułamek-Kozioł M, Furmaga-Jabłońska W, Januszewski S, Brzozowska J, Ściślewska M, Jabłoński M, Pluta R. Neuronal autophagy: Self-eating or self-cannibalism in Alzheimer's disease. Neurochem Res. 2013;38:1769–73. doi:10.1007/s11064-013-1082-4.
9. Nixon RA. The role of autophagy in neurodegenerative disease. Nat Med. 2013;19:983–97. doi:10.1038/nm.3232.
10. Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015;16:345–57. doi:10.1038/nrn3961.
11. Bento CF, Renna M, Ghislat G, Puri C, Ashkenazi A, Vicinanza M, Menzies FM, Rubinsztein DC. Mammalian Autophagy: How Does It Work? Ann Rev Biochem. 2016;85:685–713. doi:10.1146/annurev-biochem-060815-014556.
12. Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and tau effects on cognitive impairments. J Biol Chem. 2010;285:13107–20. doi:10.1074/jbc.M110.100420.
13. Nixon RA, Yang D-S. Autophagy failure in Alzheimer's disease—locating the primary defect. Neurobiol Dis. 2011;43:38–45. doi:10.1016/j.nbd.2011.01.021.
14. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA. Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer's disease. J Neurosci. 2008;28:6926–37. doi:10.1523/JNEUROSCI.0800-08.2008.
15. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. J Clin Invest. 2008;118:2190–9.
16. Jaeger PA, Pickford F, Sun C-H, Lucin KM, Masliah E, Wyss-Coray T. Regulation of amyloid precursor protein processing by the Beclin 1 complex. PloS One. 2010;5:e11102. doi:10.1371/journal.pone.0011102.
17. Swaminathan G, Zhu W, Plowey ED. BECN1/Beclin 1 sorts cell-surface APP/amyloid β precursor protein for lysosomal degradation. Autophagy. 2016;12:2404–19. doi:10.1080/15548627.2016.1234561.
18. Nilsson P, Loganathan K, Sekiguchi M, Matsuba Y, Hui K, Tsubuki S, Tanaka M, Iwata N, Saito T, Saido TC. Aβ secretion and plaque formation depend on autophagy. Cell Rep. 2013;5:61–9. doi:10.1016/j.celrep.2013.08.042.
19. Nilsson P, Sekiguchi M, Akagi T, Izumi S, Komori T, Hui K, Sörgjerd K, Tanaka M, Saito T, Iwata N, et al. Autophagy-related protein 7 deficiency in amyloid β (aβ) precursor protein transgenic mice decreases aβ in the multivesicular bodies and induces aβ accumulation in the golgi. Am J Pathol. 2015;185:305–13. doi:10.1016/j.ajpath.2014.10.011.
20. Xiao Q, Yan P, Ma X, Liu H, Perez R, Zhu A, Gonzales E, Tripoli DL, Czerniewski L, Ballabio A, et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing Aβ generation and amyloid plaque pathogenesis. J Neurosci. 2015;35:12137–51. doi:10.1523/JNEUROSCI.0705-15.2015.
21. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer's disease. PloS One. 2010;5:e9979. doi:10.1371/journal.pone.0009979.
22. Li X, He L, Che KH, Funderburk SF, Pan L, Pan N, Zhang M, Yue Z, Zhao Y. Imperfect interface of Beclin1 coiled-coil domain regulates homodimer and heterodimer formation with Atg14L and UVRAG. Nat Commun. 2012;3:662. doi:10.1038/ncomms1648.
23. Baskaran S, Carlson L-A, Stjepanovic G, Young LN, Grob P, Kim DJ, Stanley RE, Nogales E, Hurley JH. Architecture and dynamics of the autophagic phosphatidylinositol 3-kinase complex. Elife. 2014;3:e05115. doi:10.7554/eLife.05115.
24. Funderburk SF, Wang QJ, Yue Z. The Beclin 1–VPS34 complex–at the crossroads of autophagy and beyond. Trends Cell Biol. 2010;20:355–62. doi:10.1016/j.tcb.2010.03.002.
25. Cao Y, Wang Y, Saab WFA, Yang F, Pessin JE, Backer JM. NRBF2 regulates macroautophagy as a component of Vps34 Complex I. Biochem J. 2014;461:315–22. doi:10.1042/BJ20140515.
26. Zhong Y, Morris DH, Jin L, Patel MS, Karunakaran SK, Fu Y-J, Matuszak EA, Weiss HL, Chait BT, Wang QJ. Nrbf2 protein suppresses autophagy by modulating Atg14L protein-containing Beclin 1-Vps34 complex architecture and reducing intracellular phosphatidylinositol-3 phosphate levels. J Biol Chem. 2014;289:26021–37. doi:10.1074/jbc.M114.561134.
27. Young LN, Cho K, Lawrence R, Zoncu R, Hurley JH. Dynamics and architecture of the NRBF2-containing phosphatidylinositol 3-kinase complex I of autophagy. Proc Natl Acad Sci U S A. 2016;113(29):8224–9. doi:10.1073/pnas.1603650113.
28. Lu J, He L, Behrends C, Araki M, Araki K, Wang QJ, Catanzaro JM, Friedman SL, Zong WX, Fiel MI, et al. NRBF2 regulates autophagy and prevents liver injury by modulating Atg14L-linked phosphatidylinositol-3 kinase III activity. Nat Commun. 2014;5:3920. doi:10.1038/ncomms4920.
29. Araki Y, Ku W-C, Akioka M, May AI, Hayashi Y, Arisaka F, Ishihama Y, Ohsumi Y. Atg38 is required for autophagy-specific phosphatidylinositol 3-kinase complex integrity. J Cell Biol. 2013;203:299–313. doi:10.1083/jcb.201304123.
30. Ma X, Zhang S, He L, Rong Y, Brier LW, Sun Q, Liu R, Fan W, Chen S, Yue Z, et al. MTORC1-mediated NRBF2 phosphorylation functions as a switch for the class III PtdIns3K and autophagy. Autophagy. 2017;13:592–607. doi:10.1080/15548627.2016.1269988.
31. Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiol Aging. 2012;33:196. e29-. e40. doi:10.1016/j.neurobiolaging.2010.05.027.
32. François A, Bilan AR, Quellard N, Fernandez B, Janet T, Chassaing D, Paccalin M, Terro F, Page G. Longitudinal follow-up of autophagy and inflammation in brain of APPswePS1dE9 transgenic mice. J Neuroinflammation. 2014;11:139. doi:10.1186/s12974-014-0139-x.
33. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA. Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer's disease. J Neurosci. 2008;28:6926–37. doi:10.1523/JNEUROSCI.0800-08.2008.
34. Vidal RL, Matus S, Bargsted L, Hetz C. Targeting autophagy in neurodegenerative diseases. Trends Pharmacol Sci. 2014;35:583–91. doi:10.1016/j.tips.2014.09.002.
35. Thinakaran G, Teplow DB, Siman R, Greenberg B, Sisodia SS. Metabolism of the Swedish Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells Evidence That Cleavage at the “β-secretase” site occurs in the golgi apparatus. J Biol Chem. 1996;271:9390–7. doi:10.1074/jbc.271.16.9390.
36. Sisodia SS, St George-Hyslop PH. γ-Secretase, Notch, Aβ and Alzheimer's disease: Where do the presenilins fit in? Nat Rev Neurosci. 2002;3:281–90. doi:10.1038/nrn785.
37. Karlström H, Bergman A, Lendahl U, Näslund J, Lundkvist J. A sensitive and quantitative assay for measuring cleavage of presenilin substrates. J Biol Chem. 2002;277:6763–6. doi:10.1074/jbc.C100649200.
38. Yasumo H, Masuda N, Furusawa T, Tsukamoto T, Sadano H, Osumi T. Nuclear receptor binding factor-2 (NRBF-2), a possible gene activator protein interacting with nuclear hormone receptors. Biochim Biophys Acta. 2000;1490:189–97. doi:10.1016/S0167-4781(99)00244-4.
39. Flores AM, Li L, Aneskievich BJ. Isolation and functional analysis of a keratinocyte-derived, ligand-regulated nuclear receptor comodulator. J Invest Dermatol. 2004;123:1092–101. doi:10.1111/j.0022-202X.2004.23424.x.
40. Parr C, Carzaniga R, Gentleman SM, Van Leuven F, Walter J, Sastre M. Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein. Mol Cell Biol. 2012;32:4410–8. doi:10.1128/MCB.00930-12.
41. Homewood C, Warhurst D, Peters W, Baggaley V. Lysosomes, pH and the anti-malarial action of chloroquine. Nature. 1972;23:50–2. doi:10.1038/235050a0.
42. Tian Y, Bustos V, Flajolet M, Greengard P. A small-molecule enhancer of autophagy decreases levels of Aβ and APP-CTF via Atg5-dependent autophagy pathway. FASEB J. 2011;25:1934–42. doi:10.1096/fj.10-175158.
43. Thinakaran G, Koo EH. Amyloid precursor protein trafficking, processing, and function. J Biol Chem. 2008;283:29615–9. doi:10.1074/jbc.R800019200.
44. Morel E, Chamoun Z, Lasiecka ZM, Chan RB, Williamson RL, Vetanovetz C, Dall'Armi C, Simoes S, Point Du Jour KS, McCabe BD, et al. Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nat Commun. 2013;4:2250. doi:10.1038/ncomms3250.
45. Lawe DC, Chawla A, Merithew E, Dumas J, Carrington W, Fogarty K, Lifshitz L, Tuft R, Lambright D, Corvera S. Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J Biol Chem. 2002;277:8611–7. doi:10.1074/jbc.M109239200.
46. Stenmark H, Parton RG, Steele-Mortimer O, Lütcke A, Gruenberg J, Zerial M. Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J. 1994;13:1287.
47. Kroemer G. Autophagy: A druggable process that is deregulated in aging and human disease. J Clin Invest. 2015;125:1–4. doi:10.1172/JCI78652.
48. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee J-H, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, et al. Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol. 2005;171:87–98. doi:10.1083/jcb.200505082.
49. Shen H-M, Mizushima N. At the end of the autophagic road: An emerging understanding of lysosomal functions in autophagy. Trends Biochem Sci. 2014;39:61–71. doi:10.1016/j.tibs.2013.12.001.
50. Zhang X, Garbett K, Veeraraghavalu K, Wilburn B, Gilmore R, Mirnics K, Sisodia SS. A role for presenilins in autophagy revisited: Normal acidification of lysosomes in cells lacking PSEN1 and PSEN2. J Neurosci. 2012;32:8633–48. doi:10.1523/JNEUROSCI.0556-12.2012.
51. Reddy K, Cusack CL, Nnah IC, Khayati K, Saqcena C, Huynh TB, Noggle SA, Ballabio A, Dobrowolski R. Dysregulation of nutrient sensing and CLEARance in presenilin deficiency. Cell Rep. 2016;14:2166–79. doi:10.1016/j.celrep.2016.02.006.
52. Salminen A, Kaarniranta K, Kauppinen A, Ojala J, Haapasalo A, Soininen H, Hiltunen M. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. Prog Neurobiol. 2013;106:33–54. doi:10.1016/j.pneurobio.2013.06.002.
53. Fader C, Colombo M. Autophagy and multivesicular bodies: Two closely related partners. Cell Death Differ. 2009;16:70–8. doi:10.1038/cdd.2008.168.
54. McKnight NC, Zhong Y, Wold MS, Gong S, Phillips GR, Dou Z, Zhao Y, Heintz N, Zong WX, Yue Z. Beclin 1 is required for neuron viability and regulates endosome pathways via the UVRAG-VPS34 complex. PLoS Genet. 2014;10:e1004626. doi:10.1371/journal.pgen.1004626.
55. Durairajan SSK, Liu L-F, Lu J-H, Koo I, Maruyama K, Chung SK, Huang JD, Li M. Stimulation of non-amyloidogenic processing of amyloid-β protein precursor by cryptotanshinone involves activation and translocation of ADAM10 and PKC-α. J Alzheimer's Dis. 2011;25:245–62.
56. Podlisny MB, Ostaszewski BL, Squazzo SL, Koo EH, Rydell RE, Teplow DB, Selkoe DJ. Aggregation of secreted amyloid-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem. 1995;270:9564–70. doi:10.1074/jbc.270.16.9564.
57. Gómez-Suaga P, Rivero-Ríos P, Fdez E, Ramírez MB, Ferrer I, Aiastui A, López De Munain A, Hilfiker S. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity. Hum Mol Genet. 2014;23:6779–96. doi:10.1093/hmg/ddu395.